STAT5 and Prolactin Participate in a Positive Autocrine Feedback Loop That Promotes Angiogenesis

Molecular Mechanisms of Prolactin and Its Receptor

(2012) Charles L. Brooks   ENDOCRINE REVIEWS

The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors

(2011) E. A. Nelson et al.   BLOOD

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Angiogenesis Induced by Signal Transducer and Activator of Transcription 5A (STAT5A) Is Dependent on Autocrine Activity of Proliferin

(2011) Xinhai Yang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Functional consequences of prolactin signalling in endothelial cells: a potential link with angiogenesis in pathophysiology?

(2011) Anne Q. Reuwer et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Dual inhibition of Jak2 and STAT5 enhances killing of myeloproliferative neoplasia cells

(2011) M Bar-Natan et al.   LEUKEMIA

Molecular mechanisms and clinical applications of angiogenesis

(2011) Peter Carmeliet et al.   NATURE

New concepts in prolactin biology

(2010) Sophie Bernichtein et al.   JOURNAL OF ENDOCRINOLOGY

Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors

(2010) V. Rouet et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Signal Transducers and Activators of Transcription Mediate Fibroblast Growth Factor–Induced Vascular Endothelial Morphogenesis

(2009) Xinhai Yang et al.   CANCER RESEARCH

Prolactin in Ovarian Follicular Fluid Stimulates Endothelial Cell Proliferation

(2009) Alejandra Castilla et al.   JOURNAL OF VASCULAR RESEARCH

Stat3 mediates myeloid cell–dependent tumor angiogenesis in mice

(2008) Maciej Kujawski et al.   JOURNAL OF CLINICAL INVESTIGATION

The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies

(2008) Birk Poller et al.   JOURNAL OF NEUROCHEMISTRY